The effect of PGRN on liver fibrosis has not been investigated, but based on these findings, it is conceivable that PGRN might inhibit inflammation during chronic liver disease by modulating tumor necrosis factor-α (TNF-α) signaling. This evidence concerns the gene TNF and Hepatic fibrosis.